Exon 9 and exon 20 mutations inPIK3CAconfer resistance to HER2 inhibitors in HER2-overexpressing breast cancer cells.
2021 ◽
Keyword(s):
Keyword(s):
Keyword(s):
2015 ◽
Vol 12
(02)
◽
Keyword(s):
2017 ◽